Variant report

Variant	rs62441825
Chromosome Location	chr6:150283907-150283908
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	TEAD4	chr6:150283868-150285282	K562	blood:	n/a	n/a
2	JUN	chr6:150283455-150285912	K562	blood:	n/a	chr6:150284356-150284366 chr6:150284350-150284362 chr6:150284356-150284366 chr6:150284358-150284369 chr6:150284356-150284366 chr6:150284356-150284366 chr6:150284357-150284365
3	POLR2A	chr6:150283904-150285319	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:150276072..150278660-chr6:150282863..150284944,2	K562	blood:
2	chr6:150281848..150284809-chr6:150294278..150296186,2	MCF-7	breast:

Variant related genes	Relation type
ULBP1	TF binding region

Extended variants
information (count: 45 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:42)

rs_ID	r²[population]
rs10499261	0.96[ASN][1000 genomes]
rs12110592	0.87[ASN][1000 genomes]
rs12523670	0.87[ASN][1000 genomes]
rs12527074	0.87[ASN][1000 genomes]
rs12529569	0.87[ASN][1000 genomes]
rs12530097	0.83[ASN][1000 genomes]
rs12662588	0.87[ASN][1000 genomes]
rs12663861	0.85[ASN][1000 genomes]
rs1577353	0.88[ASN][1000 genomes]
rs17079117	0.94[ASN][1000 genomes]
rs17079127	0.94[ASN][1000 genomes]
rs17079130	0.96[ASN][1000 genomes]
rs1977656	0.80[ASN][1000 genomes]
rs2018074	0.87[ASN][1000 genomes]
rs2181918	0.83[ASN][1000 genomes]
rs2343264	0.87[ASN][1000 genomes]
rs3860818	0.87[ASN][1000 genomes]
rs4084448	0.93[ASN][1000 genomes]
rs4354166	0.83[ASN][1000 genomes]
rs4425606	0.84[AFR][1000 genomes];0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs56370653	0.88[ASN][1000 genomes]
rs61158421	0.88[ASN][1000 genomes]
rs61233579	0.84[ASN][1000 genomes]
rs61298074	0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs62441832	0.84[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs62441834	0.86[AMR][1000 genomes];0.95[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs73779712	0.87[ASN][1000 genomes]
rs73779717	0.86[ASN][1000 genomes]
rs73779721	0.87[ASN][1000 genomes]
rs73779728	0.86[ASN][1000 genomes]
rs73779729	0.86[ASN][1000 genomes]
rs73779733	0.86[ASN][1000 genomes]
rs7454183	0.85[ASN][1000 genomes]
rs7740713	0.96[ASN][1000 genomes]
rs7744918	0.94[ASN][1000 genomes]
rs7745903	0.84[ASN][1000 genomes]
rs7749024	0.87[ASN][1000 genomes]
rs7760608	0.96[ASN][1000 genomes]
rs7763485	0.85[ASN][1000 genomes]
rs7763772	0.87[ASN][1000 genomes]
rs7767362	0.94[ASN][1000 genomes]
rs9791229	0.92[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv886764	chr6:150114745-150393683	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
2	nsv517022	chr6:150145001-150426272	Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
3	nsv886765	chr6:150198491-150288722	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS ZNF genes & repeats Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:7 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150283800-150284000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
2	chr6:150283800-150284200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
3	chr6:150283800-150284200	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr6:150283800-150284200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr6:150283800-150284200	Enhancers	HSMM	muscle
6	chr6:150283800-150284400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
7	chr6:150283800-150284600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links